Home merck
 

Keywords :   


Tag: merck

Merck To Present At Cowen Healthcare Conference

2014-03-04 20:38:06| Merck.com - Financial News

Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J., Mar. 4, 2014 Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Peter N. Kellogg, executive vice president and chief financial officer, Merck is scheduled to present at the Cowen Healthcare Conference in Boston on March 5, 2014 at 9:20 a.m. EST. Language: English Ticker Slug: Ticker: MRK Exchange: NYSE Contacts Media Contacts: Kelley P. Dougherty, 267-305-3552 Investor Contacts: Joe Romanelli, 908-423-5185 read more

Tags: present conference healthcare merck

 

Merck Announces Second-Quarter 2014 Dividend

2014-02-25 18:31:00| Merck.com - Corporate News

Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the Board of Directors has declared a quarterly dividend of $0.44 per share of the companys common stock for the second quarter of 2014. Payment will be made on April 7, 2014, to stockholders of record at the close of business on March 17, 2014. About Merck Language: English Contact: MerckMedia:Kelley Dougherty, 267-305-3552Investor:Carol Ferguson, 908-423-4465 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: announces dividend merck announces dividend

 
 

Merck to Participate in the Citi 2014 Healthcare Conference

2014-02-20 23:00:00| Merck.com - Corporate News

Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that Dr. Roger M. Perlmutter, president, Merck Research Laboratories, is scheduled to speak at the Citi 2014 Healthcare Conference in New York City on February 24, 2014 at 8:50 a.m. EST. Investors, analysts, members of the media and the general public are invited to join a live webcast of the presentation at: http://www.merck.com/investors/events-and-presentations/home.html. About Merck Language: English Contact: MerckMedia:Kelley Dougherty, 267-305-3552orInvestors:Justin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: conference participate healthcare merck

 

How Merck Saved $30 Million by Revamping Global Fleet

2014-02-16 21:27:42| AutomotiveDigest.com - Automotive Industry News

Joe Carreira is Mercks fleet manager for Europe, the Middle East and Africa, and was named 2012 International Fleet Manager of the Year. A highly respected fleet professional, Joe was a faculty member for NAFAs 3rd Annual International Fleet Academy. We talked with him about Merck's global fleet operations and its need to change, to "optimize and harmonize," and in doing so, delivering $30 million of cost savings in just three years.The Article How Merck Saved $30 Million by Revamping Global Fleet appeared first on Automotive Digest.

Tags: global million saved fleet

 

Merck and Samsung Bioepis Enter Collaboration Agreement to Develop and Commercialize Insulin Glargine Candidate for Diabetes

2014-02-10 14:43:00| Merck.com - Corporate News

Dateline City: WHITEHOUSE STATION, N.J. & SEOUL, SOUTH KOREA WHITEHOUSE STATION, N.J. & SEOUL, SOUTH KOREA--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Samsung Bioepis Co., Ltd., announced today that they have expanded their collaboration with an agreement to develop, manufacture and commercialize MK-1293, an insulin glargine candidate for the treatment of patients with type 1 and type 2 diabetes. Phase III clinical studies in type 1 and type 2 diabetes will begin soon. Language: English Contact: Merck Media InquiriesKim Hamilton, 908-423-6831orCaroline Lappetito, 267-305-7639orMerck Investor RelationsCarol Ferguson, 908-423-4465orSamsung Media InquiriesHongSeok Ji, +82-32-455-6102orSamsung Investor RelationsSungjoon Park, +82-32-455-6120 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: for enter agreement develop

 

Sites : [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] next »